These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 13799977)

  • 1. Metabolism of dlepinephrine-beta-C14 in plasma of schizophrenics.
    BERTHIAUME M; LEDUC J; D'IORIO A
    AMA Arch Gen Psychiatry; 1960 Apr; 2():468-9. PubMed ID: 13799977
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of serum from schizophrenics on epinephrine-sensitive elements in the rabbit brain.
    MINZ B; WALASZEK EJ
    J Nerv Ment Dis; 1960 May; 130():420-5. PubMed ID: 14422811
    [No Abstract]   [Full Text] [Related]  

  • 3. Iproniazid treatment and metabolism of labeled epinephrine in schizophrenics.
    RESNICK O; WOLFE JM; FREEMAN H; ELMADJIAN F
    Science; 1958 May; 127(3306):1116-7. PubMed ID: 13555854
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on aminochromes. 3. Transformation of epinephrine, adrenochrome and adrenolutin into plasma-soluble melanins during incubation in human blood plasma.
    Hegedus ZL; Altschule MD
    Arch Biochem Biophys; 1968 Aug; 126(2):388-92. PubMed ID: 5672506
    [No Abstract]   [Full Text] [Related]  

  • 5. Elevated plasma dopamine concentrations in unmedicated acute schizophrenics.
    Sarai M; Matsunaga H; Kimura S
    Jpn J Psychiatry Neurol; 1990 Sep; 44(3):557-62. PubMed ID: 2074615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vitro oxidation of epinephrine in plasma.
    HEATH RG; LEACH BE
    AMA Arch Neurol Psychiatry; 1956 Oct; 76(4):444-50. PubMed ID: 13361606
    [No Abstract]   [Full Text] [Related]  

  • 7. The stability of epinephrine and arterenol (norepinephrine) in plasma and serum; a comparison of normal and schizophrenic subjects.
    COHEN G; HOLLAND B; GOLDENBERG M
    AMA Arch Neurol Psychiatry; 1958 Oct; 80(4):484-7. PubMed ID: 13582284
    [No Abstract]   [Full Text] [Related]  

  • 8. The phsiological and psychological effects of intravenously administered epinephrine, and its metabolism, in normal and schizophrenic men. III. Metabolism of 7-H3-epinephrine as determined in studies on blood and urine.
    LABROSSE EH; MANN JD; KETY SS
    J Psychiatr Res; 1961 Oct; 1():68-75. PubMed ID: 14461334
    [No Abstract]   [Full Text] [Related]  

  • 9. Disappearance rates of infused epinephrine and norepinephrine from plasma: a comparison of normal and schizophrenic subjects.
    COHEN G; HOLLAND B; GOLDENBERG M
    AMA Arch Gen Psychiatry; 1959 Aug; 1():228-31. PubMed ID: 13810947
    [No Abstract]   [Full Text] [Related]  

  • 10. Concentrations of beta-phenylethylamine in plasma and plateletes of schizophrenics.
    Myojin T; Taga C; Tsuji M
    Jpn J Psychiatry Neurol; 1989 Jun; 43(2):171-6. PubMed ID: 2796027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resting urinary catecholamine excretion in schizophrenics: methodology and interpretation of results.
    Barbeito L; Lista A; Silveira R; Dajas F
    Biol Psychiatry; 1984 Oct; 19(10):1419-25. PubMed ID: 6518199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of blood serum from schizophrenic patients on the content of catecholamines in aminal brain tissue].
    Davydova IB; Minsker EI; Orlovskaia DD
    Vopr Med Khim; 1966; 12(2):150-4. PubMed ID: 6001582
    [No Abstract]   [Full Text] [Related]  

  • 13. The relative metabolic rates of norepinephrine-7H3 and epinephrine-1-C14.
    GOLDSTEIN M; FRIEDHOFF AJ; SANDLER G
    Experientia; 1960 May; 16():211. PubMed ID: 13850777
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of iproniazid on the metabolism of dl-epinephrine-2-C14 in the human.
    KIRSHNER N; GOODALL M; ROSEN L
    J Pharmacol Exp Ther; 1959 Sep; 127():1-7. PubMed ID: 14409393
    [No Abstract]   [Full Text] [Related]  

  • 15. 24-hour plasma levels of prolactin, cortisol, growth hormone and catecholamines in schizophrenic patients.
    Kemali D; Maj M; Ariano MG; Arena F; Lovero N
    Neuropsychobiology; 1985; 14(3):109-14. PubMed ID: 3831798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pharmacological doses of 2-deoxyglucose on plasma catecholamines and glucose levels in patients with schizophrenia.
    Elman I; Rott D; Green AI; Langleben DD; Lukas SE; Goldstein DS; Breier A
    Psychopharmacology (Berl); 2004 Nov; 176(3-4):369-75. PubMed ID: 15179540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diurnal rhythm of plasma beta endorphin, cortisol and growth hormone in schizophrenics as compared to control subjects.
    Gil-Ad I; Dickerman Z; Amdursky S; Laron Z
    Psychopharmacology (Berl); 1986; 88(4):496-9. PubMed ID: 2939487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenaline metabolites and schizophrenia.
    HOFFER A
    Dis Nerv Syst; 1960 Feb; 21(2)Suppl():79-86. PubMed ID: 14402369
    [No Abstract]   [Full Text] [Related]  

  • 19. The metabolism of epinephrine-containing isotopic carbon in man.
    RESNICK O; ELMADJIAN F
    J Clin Endocrinol Metab; 1958 Jan; 18(1):28-35. PubMed ID: 13491681
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biochemical problems in schizophrenia research].
    MARTENS S
    Sven Lakartidn; 1958 Mar; 55(12):809-22. PubMed ID: 13543704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.